Velsipity (etrasimod)

infections: May increase the risk of infections. Obtain a complete blood count (CBC) before initiation of treatment. Monitor for infection during treatment and for 5 weeks after discontinuation. Consider interruption of treatment if a serious infection develops. Avoid the use of live attenuated vaccines during and for up to 5 weeks after treatment.

Bradyarrhythmia and Atrioventricular Conduction Delays: This may result in a transient decrease in heart rate and AV conduction delays. Obtain an electrocardiogram (ECG) to assess for preexisting cardiac conduction abnormalities before starting treatment. Consider cardiology consultation for conduction abnormalities or concomitant use with other drugs that decrease heart rate.  

Liver Injury: Elevations of aminotransferases may occur. Obtain transaminase and bilirubin levels before initiating Velsipity. Discontinue if significant liver injury is confirmed. 

Macular Edema: This may increase the risk of macular oedema. Obtain a baseline evaluation of the fundus, including the macula, near the start of treatment with Velsipity. Periodically conduct an evaluation of the fundus, including the macula, while on therapy and any time there is a change in vision. Consider discontinuing Velsipity if macular oedema develops.

 Increased Blood Pressure: Monitor blood pressure during treatment.

Fetal Risk: This may cause fetal harm. Advise females of reproductive potential of the potential risk to a fetus and to use effective contraception during treatment and for one week after stopping Velsipity. 

Malignancies: Obtain a skin examination prior to or shortly after the start of treatment and periodically during treatment, especially if risk factors. Promptly evaluate suspicious skin lesions. 

Posterior Reversible Encephalopathy Syndrome (PRES): If symptoms develop, obtain a physical and neurological exam and consider an MRI. 

Respiratory Effects: May cause a decline in pulmonary function. Assess pulmonary function (e.g., spirometry) if clinically indicated. Unintended Additive Immune System Effects from Prior Treatment with Immunosuppressive or Immune-Modulating Drugs: Consider the half-life and mode of action of prior therapies.  Immune System Effects After Stopping Velsipity: If using concomitant immunosuppressants, monitor patients for infectious complications for up to 5 weeks after the last dose of Velsipity 2 mg.

What documents are required to import Velsipity to India?

Validity can be imported by patients or government hospitals in the name of the patients only. 

The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
  
• Patients diagnostic reports
  
• Patient ID proof (issued by the government of India)

• The order will be confirmed only after the receipt of:
  
• Valid prescription of Doctor
  
• Import permit, if applicable

Velsipity is a (prescription drug, prescription medication or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input

• On availability in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore and Pune etc.)
  
• Medicine Price.
  
•  Finding Genuine and reliable sources from Canada, Europe, the USA, and Australia
  
• Ensuring 100% transparency.

 Indian Pharma Network can facilitate the supply of Velsipity (prescription medicines) to all locations in the world and India after fulfilling the legal requirement (if applicable). 

 Please contact or mail @ – info@indianpharmanetwork.in +91 9310090915- Toll-Free – 1800-889-1064 for Velsipity price in India. 

 We guarantee quality and delivery anywhere in the world as per the buyer’s requirements. 

Indian Pharma Network is able to source the Velsipity Injection (immunosuppressant) from across the globe, and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.

 Indian Pharma Network is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.Indian Pharma Network helps to connect patients with potential distributors, wholesalers, suppliers and dealers of Velsipity in India.

What is Velsipity used for?

Healthcare professionals use velsipity for the treatment of moderately to severely active ulcerative colitis (UC) in adults.

Is Velsipity a biologic?

Velsipity is not an infusion or an injection. It’s also not a steroid or a biologic.

What is the mechanism of action of Velsipity?

Etrasimod partially and reversibly blocks the capacity of lymphocytes to egress from lymphoid organs, reducing the number of lymphocytes in peripheral blood. The mechanism by which etrasimod exerts therapeutic effects in UC is unknown but may involve the reduction of lymphocyte migration into the intestines. 

What are the side effects of Vesipity?

The common side effects of Vesipity are headache, elevated liver tests, and dizziness.

What is the price of Velsipity in India?

To know the Velsipity price in India, you can call or WhatsApp +91-9310090915 or email info@indianpharmanetwork.in.